Safety of Simvastatin and Goal Attainment for Low-Density Lipoprotein Cholesterol in Sultan Qaboos University Hospital

OBJECTIVES: Despite the scientific evidence of reducing cardiac events with HMG Co-A reductase inhibitors (statins) therapy in both primary and secondary preventions, these therapies continue to be underutilized in patients receiving convictional care. Simvastatin, a HMG Co-A inhibitor agent, is the...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Al-Siyabi, Khalid, Farhan, Hatem, Al-Rasadi, Khalid, Al-Salhi, Amaal, Al-Hinai, Ali T., Al-Zakwani, Ibrahim
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: OMJ 2010
Konular:
Original Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3191659/
https://ncbi.nlm.nih.gov/pubmed/22043355
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5001/omj.2010.79
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller